Small molecule inhibition of ATM kinase increases CRISPR-Cas9 1-bp insertion frequency
The mutational outcome of CRISPR-Cas9 editing can be both predictable and targeted. Here the authors show that ATM inhibitor KU-60019 increases 1 bp insertions at the targeted locus.
Guardado en:
Autores principales: | Heysol C. Bermudez-Cabrera, Sannie Culbertson, Sammy Barkal, Benjamin Holmes, Max W. Shen, Sophia Zhang, David K. Gifford, Richard I. Sherwood |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77675116590e4b8aa7e1d10c6a4309b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structure of the intact ATM/Tel1 kinase
por: Xuejuan Wang, et al.
Publicado: (2016) -
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
por: Rajeswari Jayavaradhan, et al.
Publicado: (2019) -
CRISPR-Cas9 Mediated Labelling Allows for Single Molecule Imaging and Resolution
por: Abdullah O. Khan, et al.
Publicado: (2017) -
ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer
por: Sabrina Putti, et al.
Publicado: (2021) -
CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome
por: Ha Youn Shin, et al.
Publicado: (2017)